Cargando…
Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
Cardiovascular diseases (CVD) are still the prevailing cause of death not only in industrialized countries, but even worldwide. Type 2 diabetes mellitus (type 2 DM) and hyperlipidemia, a metabolic disorder that is often associated with diabetes, are major risk factors for developing CVD. Recently, c...
Autores principales: | Vedantham, Srinivasan, Kluever, Anna-Kristina, Deindl, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210696/ https://www.ncbi.nlm.nih.gov/pubmed/30360455 http://dx.doi.org/10.3390/cells7100181 |
Ejemplares similares
-
The Extraordinary Role of Extracellular RNA in Arteriogenesis, the Growth of Collateral Arteries
por: Kluever, Anna-Kristina, et al.
Publicado: (2019) -
Insulin Treatment Forces Arteriogenesis in Diabetes Mellitus by Upregulation of the Early Growth Response-1 (Egr-1) Pathway in Mice
por: Thulasingam, Senthilkumar, et al.
Publicado: (2019) -
Arteriogenesis and Therapeutic Angiogenesis—An Update
por: Deindl, Elisabeth, et al.
Publicado: (2021) -
Arteriogenesis and Therapeutic Angiogenesis in Its Multiple Aspects
por: Deindl, Elisabeth, et al.
Publicado: (2020) -
Rag1 Deficiency Impairs Arteriogenesis in Mice
por: Kumaraswami, Konda, et al.
Publicado: (2023)